Calmare Therapeutics (OTCMKTS:CTTC) versus Quipt Home Medical (NASDAQ:QIPT) Head to Head Contrast

Calmare Therapeutics (OTCMKTS:CTTCGet Rating) and Quipt Home Medical (NASDAQ:QIPTGet Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Profitability

This table compares Calmare Therapeutics and Quipt Home Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Calmare Therapeutics N/A N/A N/A
Quipt Home Medical 6.63% 3.33% 1.84%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Calmare Therapeutics and Quipt Home Medical, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Calmare Therapeutics 0 0 0 0 N/A
Quipt Home Medical 0 0 4 0 3.00

Quipt Home Medical has a consensus target price of $9.75, indicating a potential upside of 81.90%. Given Quipt Home Medical’s higher possible upside, analysts plainly believe Quipt Home Medical is more favorable than Calmare Therapeutics.

Institutional & Insider Ownership

19.4% of Quipt Home Medical shares are owned by institutional investors. 17.5% of Calmare Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Calmare Therapeutics and Quipt Home Medical’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Calmare Therapeutics N/A N/A N/A N/A N/A
Quipt Home Medical $102.35 million 1.76 -$6.17 million $0.25 21.44

Calmare Therapeutics has higher earnings, but lower revenue than Quipt Home Medical.

Summary

Quipt Home Medical beats Calmare Therapeutics on 7 of the 8 factors compared between the two stocks.

About Calmare Therapeutics

(Get Rating)

Calmare Therapeutics, Inc. engages in the research, development, and commercialization of chronic, neuropathic pain and wound affliction devices. It offers licensing and technology sourcing. The company was founded in 1968 and is headquartered in Fairfield, CT.

About Quipt Home Medical

(Get Rating)

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

Receive News & Ratings for Calmare Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calmare Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.